Search results for #EliLilly
🔥#BreakingNews Major movements in the #SP500 on April 31, 2024: $LDOS #LeidosHoldingsInc +6.53% USD $140.22 $LLY #EliLilly&Co +5.95% USD $781.10 $TT #TraneTechnologiesPLC +5.48% USD $317.34 $GLW #CorningInc +5.03% USD $33.38 $ZBRA #ZebraTechnologiesCorpClA +4.85% USD…
@EliLillyandCo shared their earnings report with investors today. Here’s my short-form reaction. Full reaction coming soon to the #podcast #mounjaro #zepbound #releasethevials #elililly #trulicity #eloralintide
| $LLY 10-Q Summary (2024-04-30) Stock Buyback: 0 USD (-100% YoY) Net Income: 2.24B USD (+67% YoY) Earnings Per Share: 2.49 USD/Share (+67% YoY) #Stocks #Investing #SEC #EliLilly
🤖 $LLY #ELILILLY - 1 uur: ELI LILLY AND CO. maakt een erg sterke bullish trend door. Traders kunnen overwegen alleen longposities te handelen (op moment van aankoop) zolang de... centralcharts.com/nl/1956-eli-li…
2/3 💉💊 Las acciones de #EliLilly subieron 5% después de que el gigante farmacéutico informara ganancias gracias a las fuertes ventas de su exitoso medicamento para la diabetes Mounjaro y el recién lanzado tratamiento para bajar de peso Zepbound.
$LLY and Novo Nordisk could see significant shifts in long-term outlooks with expanded GLP-1 use. Improved diabetes management and potential market growth may reshape their trajectories: ibn.fm/zZCyk #EliLilly #NovoNordisk #DiabetesCare #HealthcareTrends
$LLY Update(+6.5%/earnings): linkedin.com/posts/gary-mor…, #elililly @EliLillyandCo $PPH #healthcaresector
¡Buenas tardes! 😀 Apertura de #WallStreet con #EliLilly en el foco tras la presentación de #resultados 💉 🔸También #BBVA y #Sabadell protagonizan la sesión con rumores de #fusión🔴 #bolsas #mercados Consulta los niveles aquí 👇 eu1.hubs.ly/H08TTrR0
#EliLilly Q1 Highlights: ▪️Revenue up 26% driven by Mounjaro, Zepbound, Verzenio, Jardiance ▪️Raised 2024 revenue guidance by $2B ▪️Earnings per share up 66% ▪️Key pipeline advances: #tirzepatide, mirikizumab, lebrikizumab ▪️Expanding manufacturing for future growth #pharma…
Headline: “💊 Eli Lilly’s Earnings Uncertainty Amid Booming Drug Sales”Link: Read More glcnd.com/health/why-eli… “Despite strong sales of anti-obesity drugs, Eli Lilly faces earnings uncertainty. What factors might be impacting their financial outlook? #EliLilly #Healthcare”
イーライリリー、2024年業績見通しを上方修正-肥満症治療薬が好調 bloomberg.co.jp/news/articles/… ”肥満症治療薬「ゼップバウンド」と糖尿病治療薬「マンジャロ」の供給状況が改善し、クーポンで製品を購入する患者が減るため、今後収益が増加する見通しだ” 株価 7%高 $LLY #EliLilly